| Date | Title | Description |
| 26.07.2017 | Term Sheet — Wednesday, July 26 | MORE CRYPTO
Good morning. It’s Jen Wieczner taking over your Term Sheet today while Erin is away. Please send me your feedback at jen.wieczner@fortune.com and/or follow and DM me on Twitter: @jenwieczner.
Paid Content What you need to know ... |
| 16.06.2015 | Kezar Life Sciences Completes $23M Series A Financing | Kezar Life Sciences, a South San Francisco, CA-based company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders, completed a $23m Series A financing.
Backers included Morningside Venture... |
| - | Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 11, 2021--
Kezar Life Sciences, Inc. (Nasdaq: KZR ), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, to... |
| - | Kezar Life Sciences to Participate at Cowen 41st Annual Virtual Health Care Conference | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 25, 2021--
Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, toda... |
